Switching to Manuscript Central Online Submission System

 

Starting September 2021, International Journal of Bioprinting (IJB) will be using dual online submission systems until clearing all items in the OJS system, i.e., Manuscript CentralTM and OJS online submission systems. Authors are advised to make new submissions via the new submission system – Manuscript CentralTM. All subsequent revisions for papers submitted via this new system will be handled entirely on the same system. 

The existing submissions will be handled in the current OJS system until a final editorial decision is made. In other words, subsequent revisions for these papers need to be submitted via the same OJS system. Authors who want to submit to Special Issue/Special Section titled 3D Printing and Bioprinting for the Future of Healthcare should make new submissions via the OJS portal. Any irrelevant new submissions made through the OJS system will be removed, and the authors are advised to submit them via the Manuscript CentralTM portal.

Go to Online Submission and choose the correct portal for making submissions:

Portal

Purposes

Manuscript CentralTM

To make new submissions

OJS

(1) To submit revisions of existing papers in OJS

(2) To submit new submissions to Special Issue/Special Section titled 3D Printing and Bioprinting for the Future of Healthcare

 

The application of the dual online submission system will continue for a couple of months, and we will switch to using Manuscript CentralTM completely upon clearing all items in the OJS system.

Thank you.

 
Posted: 2021-09-08
 

Special Section “3D Printing and Bioprinting for the Future of Healthcare”: - Call for Papers

 

3D printing and bioprinting is a multidisciplinary technique involving design, biomaterials, life science, and medicine. This emerging field is creating an enormous opportunity for the future of healthcare. Applications of 3D printing and bioprinting in medicine are expanding at an accelerated pace, demonstrating advanced solutions in biomedical and biotechnology industry. These include new design of implant, streamlined fabrication of personalized medical product, and development of biomimetic bioinks towards complex tissues and organs.

Beyond creation, 3D printing and bioprinting also impact the delivery of future healthcare solution by capitalizing on the digital nature of the technology. New regulatory paradigm and healthcare logistics will be formulated to meet the demand of 3D printed medical devices or organs.

 
Posted: 2021-07-08 More...
 

Change of Creative Commons License

 

Starting from Volume 7 Issue 3 (2021), International Journal of Bioprinting will publish accepted manuscripts under Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors who submit their papers for publication by International Journal of Bioprinting agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source is properly cited, anyone may copy, redistribute, reuse and transform the content.

In order to fully implement Whioce Publishing’s Open Access policy, the Publisher decides to replace the original Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) with the commercial CC BY 4.0 license to ensure that the article content can be mined for research without barriers and allow greater freedom in re-using the article content.

 
Posted: 2021-02-19
 

Revision of Article Processing Charge

 
To continue supporting open access publishing and cover the production and publication costs, International Journal of Bioprinting will incur an Article Processing Charge (APC) of US$ 2,500 for the acceptance and publication of an article submitted and accepted on or after July 1, 2021. The original APC rate of US$ 800 will still apply for the articles submitted before July 1, 2021. The APC is payable after editorial acceptance of manuscripts. Articles that do not require peer-review such as letters, editorials, book reviews, corrigenda, and addenda will be published free of charge. For details of payment, please see Article Processing Charges (APC).  
Posted: 2021-02-19
 

Inclusion of International Journal of Bioprinting in Science Citation Index Expanded

 

With immense pleasure, we hereby announce that the International Journal of Bioprinting has already been accepted for inclusion by Science Citation Index Expanded (SCIE), one of the Web of Science Core Collections. The journal will be indexed in two categories of SCIE – Engineering (Biomedical) and Materials Science (Biomaterials). Coverage will begin with Volume 4 Issue 1 of the journal, and its Journal Impact Factor will be released around June 2021.

This achievement is a new milestone marked by the continuous efforts of Professor Chee Kai Chua (Editor-in-Chief), Professor Wai Yee Yeong (Associate Editor), Jiankang He (Associate Editor), Dr. Jia An (Assistant Editor), fellow Editorial Board Members of the International Journal of Bioprinting, and our editors (Dr. Ian Foo Nian Wong and Ms. Puvanesswaray Ramakrishnan). We are also indebted to all the reviewers whose expertise and evaluation form the basis of the articles’ quality and standards.

International Journal of Bioprinting will continue to uphold its integrity in science reporting and article quality.

 
Posted: 2020-12-08
 
1 - 5 of 5 Items